Together, by using different approaches to specifically deplete Tfr cells and address steady-state, immunizing and infection settings, the studies unequivocally ascribe a role for Tfr cells in preventing autoantibody responses and their pathologic consequences. The gene discussed is TFRC; the disease is infection.